摘要 |
The invention concerns a gastric-retained pharmaceutical composition, characterised in that it comprises: (a) an active principle consisting in a benzamide or a benzamide salt; (b) a system for generating carbon dioxide; and (c) means for partially retaining the carbon dioxide generated by the carbon dioxide generating means. |